Beaverswood

Activities: Regulatory

Trending Articles

  1. Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
  2. Servier opens new €86m biologics production facility in Loiret, France The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Hybrid interferons: developing a novel drug class With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These...
  4. Leybold launches Duradry vacuum pump for harsh processes Advanced technology designed for reliability and efficiency
  5. 2BScientific expands its life science product supply service to Europe with new German facility The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Regulatory

Shadow boards: a common-sense approach to effective tool management

Jim Roberts, Product Manager at Beaverswood, considers the benefits of adopting a common-sense approach to workplace tool management and organisation
Subscribe now